相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection
Maria V. Fawaz et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET
Nobuyuki Okamura et al.
BRAIN (2014)
In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease
Victor L. Villemagne et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging
Tetsuro Tago et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2014)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease
Kenji Matsumura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology
Patrick J. Riss et al.
MEDCHEMCOMM (2013)
Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease
Hiroyuki Watanabe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies
Wei Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Preventing Alzheimer's Disease
Dennis J. Selkoe
SCIENCE (2012)
18F-Labeled Phenyldiazenyl Benzothiazole for in Vivo Imaging of Neurofibrillary Tangles in Alzheimer's Disease Brains
Kenji Matsumura et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Evaluation of [11C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles
Xia Shao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains
Masahiro Ono et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Association Between In Vivo Fluorine 18-Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
David A. Wolk et al.
ARCHIVES OF NEUROLOGY (2011)
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Michelle T. Fodero-Tavoletti et al.
BRAIN (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Merits of FDDNP-PET Imaging in Alzheimer's Disease
Jonghan Shin et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Phenyldiazenyl benzothiazole derivatives as probes for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains
Kenji Matsumura et al.
MEDCHEMCOMM (2011)
Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease
Leonel E. Rojo et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
Michel Koole et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
Seok Rye Choi et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
Differentiating Alzheimer disease-associated aggregates with small molecules
Nicolette S. Honson et al.
NEUROBIOLOGY OF DISEASE (2007)
Impact of amyloid imaging on drug development in Alzheimer's disease
Chester A. Mathis et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
2-(2-[2-dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients
Yukitsuka Kudo et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
PET of brain amyloid and tau in mild cognitive impairment
Gary W. Small et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Quinoline and benzimidazole derivatives:: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease
N Okamura et al.
JOURNAL OF NEUROSCIENCE (2005)
F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain
W Zhang et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
PET imaging of amyloid in Alzheimer's disease
A Nordberg
LANCET NEUROLOGY (2004)
Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain
CA Mathis et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
CA Mathis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease
P Giannakopoulos et al.
NEUROLOGY (2003)
分享论文
